Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $931.43 | 64 | 92.9% |
| Education | $71.50 | 2 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $101.92 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $97.85 | 3 | $0 (2022) |
| Corium, LLC | $82.20 | 8 | $0 (2024) |
| Alkermes, Inc. | $81.81 | 6 | $0 (2022) |
| Allergan Inc. | $71.50 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $70.80 | 12 | $0 (2022) |
| Neuronetics, Inc. | $63.86 | 2 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $59.51 | 4 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $56.76 | 4 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $54.84 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.31 | 15 | Supernus Pharmaceuticals, Inc. ($64.54) |
| 2023 | $111.29 | 9 | Corium, LLC ($41.76) |
| 2022 | $199.89 | 11 | Teva Pharmaceuticals USA, Inc. ($76.71) |
| 2021 | $65.72 | 5 | Eisai Inc. ($15.44) |
| 2020 | $27.90 | 2 | Eisai Inc. ($14.35) |
| 2019 | $117.65 | 7 | Allergan Inc. ($31.50) |
| 2018 | $79.46 | 4 | Allergan Inc. ($40.00) |
| 2017 | $90.71 | 13 | Sunovion Pharmaceuticals Inc. ($43.40) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2022 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $76.71 | General |
| 10/20/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: CNS | ||||||
| 03/29/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: CNS | ||||||
| 03/23/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: CNS | ||||||
| 03/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Neuroscience | ||||||
| 02/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: CNS | ||||||
| 01/26/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: CNS | ||||||
| 01/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: CNS | ||||||
| 11/18/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2021 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/29/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Neurology | ||||||
| 08/03/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Central Nervous System | ||||||
| 09/15/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: Neurology | ||||||
| 02/14/2020 | Tris Pharma Inc | Quillichew ER (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: ADHD | ||||||
| 07/25/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: CNS | ||||||
| 07/11/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 06/19/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 06/18/2019 | Tris Pharma Inc | Quillivant XR (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ADHD | ||||||
| 05/23/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: CNS | ||||||
| 03/06/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/01/2019 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 694 | 1,661 | $404,110 | $85,861 |
| 2022 | 9 | 739 | 1,789 | $424,835 | $92,916 |
| 2021 | 10 | 785 | 1,883 | $420,677 | $111,997 |
| 2020 | 10 | 841 | 1,984 | $413,194 | $104,070 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 712 | $258,990 | $54,618 | 21.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 180 | 469 | $102,411 | $22,560 | 22.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 29 | 49 | $13,504 | $3,242 | 24.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $7,365 | $1,674 | 22.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 57 | 78 | $7,778 | $1,019 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 68 | 124 | $3,417 | $1,009 | 29.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 80 | $4,046 | $758.31 | 18.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 25 | 98 | $5,367 | $734.98 | 13.7% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 20 | 26 | $701.74 | $132.08 | 18.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 11 | 13 | $529.62 | $114.15 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 790 | $279,218 | $62,040 | 22.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 185 | 486 | $104,101 | $23,608 | 22.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 18 | 31 | $8,398 | $2,096 | 25.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 13 | 13 | $7,890 | $1,525 | 19.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 71 | 103 | $10,271 | $1,362 | 13.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 73 | 105 | $5,310 | $1,007 | 19.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 27 | 91 | $4,984 | $694.66 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 76 | 132 | $3,638 | $388.67 | 10.7% |
| 84450 | Liver enzyme (sgot), level | Office | 2022 | 22 | 38 | $1,026 | $194.49 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 246 | 829 | $266,358 | $76,359 | 28.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 191 | 518 | $109,868 | $26,911 | 24.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 30 | 39 | $10,483 | $2,625 | 25.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $7,025 | $2,106 | 30.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 74 | 111 | $11,069 | $1,486 | 13.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 74 | 108 | $5,462 | $1,049 | 19.2% |
About Dr. Robert Olson, MD
Dr. Robert Olson, MD is a Psychiatry healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356320279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Olson, MD has received a total of $1,003 in payments from pharmaceutical and medical device companies, with $310.31 received in 2024. These payments were reported across 66 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($931.43).
As a Medicare-enrolled provider, Olson has provided services to 3,059 Medicare beneficiaries, totaling 7,317 services with total Medicare billing of $394,844. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Mankato, MN
- Active Since 01/10/2006
- Last Updated 07/15/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1356320279
Products in Payments
- LATUDA (Drug) $70.80
- Azstarys (Drug) $68.49
- ARISTADA (Drug) $66.71
- Qelbree (Drug) $64.54
- NEUROSTAR TMS THERAPY SYSTEM (Device) $63.86
- NUPLAZID (Drug) $56.76
- WAKIX (Drug) $54.84
- VRAYLAR (Drug) $46.82
- INVEGA SUSTENNA (Drug) $41.39
- VIIBRYD (Drug) $40.00
- QELBREE (Drug) $37.38
- JORNAY PM (Drug) $31.25
- Dayvigo (Drug) $29.79
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $28.26
- TRINTELLIX (Drug) $26.39
- REXULTI (Drug) $25.53
- SUBLOCADE (Drug) $20.20
- FANAPT (Drug) $18.44
- Quillivant XR (Drug) $17.18
- Aristada 441 mg (Drug) $15.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mankato
Dr. Danielle Magness-Wellmann, Do, DO
Psychiatry — Payments: $179,693
Edward Sathoff, Md, MD
Psychiatry — Payments: $1,265
Dr. Michael Moeller, Md, MD
Psychiatry — Payments: $1,032
Sreelatha Spieker, Md, MD
Psychiatry — Payments: $802.50
Veronica Radigan, M.d, M.D
Psychiatry — Payments: $510.47
Dr. Travis Hansen, M.d, M.D
Psychiatry — Payments: $341.71